via bloomberg.com
Bayer AG (BAYN), the German maker of aspirin, is open to a “merger of equals” that would strengthen its health-care unit without paying a premium for a large acquisition, Chief Executive Officer Marijn Dekkers said.
Three or four companies may be considered Bayer’s equals in a merger of drug units, Dekkers said in an interview at Bloomberg’s headquarters in New York. He declined to elaborate.
Bayer would consider such a merger “if the stars were to be aligned,” Dekkers said during yesterday’s interview. “I would be open to making the company stronger if the right opportunity were to come.”
No comments:
Post a Comment